Literature DB >> 18826876

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM).

Kenneth Dickstein1, Alain Cohen-Solal, Gerasimos Filippatos, John J V McMurray, Piotr Ponikowski, Philip Alexander Poole-Wilson, Anna Strömberg, Dirk J van Veldhuisen, Dan Atar, Arno W Hoes, Andre Keren, Alexandre Mebazaa, Markku Nieminen, Silvia Giuliana Priori, Karl Swedberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18826876     DOI： 10.1016/j.ejheart.2008.08.005

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN： 1388-9842            Impact factor:   15.534


× No keyword cloud information.
  413 in total

1.  [Aerobic and strength training in patients with diabetes mellitus type 2 and heart failure].

Authors:  D Niederseer; J Niebauer
Journal:  Herz       Date:  2012-08       Impact factor: 1.443

2.  The impact of electronic health records on care of heart failure patients in the emergency room.

Authors:  Donald P Connelly; Young-Taek Park; Jing Du; Nawanan Theera-Ampornpunt; Bradley D Gordon; Barry A Bershow; Raymond A Gensinger; Michael Shrift; Daniel T Routhe; Stuart M Speedie
Journal:  J Am Med Inform Assoc       Date:  2011-11-09       Impact factor: 4.497

3.  Proteomic and transcriptomic analysis of heart failure due to volume overload in a rat aorto-caval fistula model provides support for new potential therapeutic targets - monoamine oxidase A and transglutaminase 2.

Authors:  Jiri Petrak; Jana Pospisilova; Miroslava Sedinova; Petr Jedelsky; Lucie Lorkova; Ondrej Vit; Michal Kolar; Hynek Strnad; Jan Benes; David Sedmera; Ludek Cervenka; Vojtech Melenovsky
Journal:  Proteome Sci       Date:  2011-11-11       Impact factor: 2.480

4.  A low pulse pressure predicts mortality in subjects with heart failure after an acute myocardial infarction: a post-hoc analysis of the CAPRICORN study.

Authors:  Colin J Petrie; Adriaan A Voors; Michele Robertson; Dirk J van Veldhuisen; Henry J Dargie
Journal:  Clin Res Cardiol       Date:  2011-09-21       Impact factor: 5.460

Review 5.  Clinical utility of exercise training in chronic systolic heart failure.

Authors:  Andrew J Stewart Coats
Journal:  Nat Rev Cardiol       Date:  2011-04-26       Impact factor: 32.419

6.  Retraction. rhBNP therapy can improve clinical outcomes and reduce in-hospital mortality compared with dobutamine in heart failure patients: a meta-analysis.

Authors:  Ming-Yi Lv; Shu-Ling Deng; Xiao-Feng Long
Journal:  Br J Clin Pharmacol       Date:  2015-11-28       Impact factor: 4.335

Review 7.  The potential role of endogenous bacteriophages in controlling invading pathogens.

Authors:  Andrzej Górski; Beata Weber-Dabrowska
Journal:  Cell Mol Life Sci       Date:  2005-03       Impact factor: 9.261

Review 8.  Digitalis for treatment of heart failure in patients in sinus rhythm.

Authors:  William B Hood; Antonio L Dans; Gordon H Guyatt; Roman Jaeschke; John J V McMurray
Journal:  Cochrane Database Syst Rev       Date:  2014-04-28

9.  Case management program for patients with chronic heart failure: effectiveness in terms of mortality, hospital admissions and costs.

Authors:  Verena Hendricks; Simone Schmidt; Achim Vogt; Detlef Gysan; Volker Latz; Ines Schwang; Reinhard Griebenow; Rainer Riedel
Journal:  Dtsch Arztebl Int       Date:  2014-04-11       Impact factor: 5.594

10.  Time trends in characteristics, clinical course, and outcomes of 13,791 patients with acute heart failure.

Authors:  Pere Llorens; Patricia Javaloyes; Francisco Javier Martín-Sánchez; Javier Jacob; Pablo Herrero-Puente; Víctor Gil; José Manuel Garrido; Eva Salvo; Marta Fuentes; Héctor Alonso; Fernando Richard; Francisco Javier Lucas; Héctor Bueno; John Parissis; Christian E Müller; Òscar Miró
Journal:  Clin Res Cardiol       Date:  2018-05-04       Impact factor: 5.460
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.